For a US national paramedic scope of practice student, describe pancreatitis including normal pancreatic anatomy and pathology, typical demographics and pertinent history, common signs and symptoms, early and late EMS assessment findings, pre‑hospital management from call to hospital transfer, chronic medications patients may be on and their purposes, and potential complications if treatment is delayed.

Pancreatitis for US National Paramedic Scope of Practice

Anatomy and Pathophysiology

Normal Pancreas

The pancreas is a vital organ located in the upper abdomen, behind the stomach, extending from the duodenum (head) to the spleen (tail). It performs two critical functions:

• Exocrine function: Produces digestive enzymes (lipase, amylase, trypsin) that break down fats, carbohydrates, and proteins
• Endocrine function: Produces insulin and glucagon to regulate blood glucose

Pathological Changes in Acute Pancreatitis

Acute pancreatitis is an inflammatory condition where digestive enzymes become prematurely activated inside the pancreas, causing the organ to digest itself 1. This autodigestion triggers:

• Mild form (80% of cases): Interstitial edema and swelling without tissue death
• Severe form (20-30% of cases): Pancreatic necrosis (tissue death), fluid collections, and systemic inflammation leading to organ failure 1

The inflammatory cascade releases cytokines into the bloodstream, potentially causing:

• Systemic inflammatory response syndrome (SIRS)
• Acute respiratory distress syndrome (ARDS)
• Acute kidney injury
• Cardiovascular collapse
• Multiple organ dysfunction syndrome (MODS)

Chronic Pancreatitis Changes

In chronic pancreatitis, repeated inflammation causes irreversible damage with progressive fibrosis (scarring), calcification, and permanent loss of both exocrine and endocrine function 2, 3. The pancreas shrinks, ducts become strictured and dilated, and normal tissue is replaced by fibrous tissue.

---

Demographics and Pertinent History

High-Risk Demographics

Gallstone pancreatitis:

• Middle-aged to elderly patients (40-70 years)
• Female predominance
• Obesity
• Rapid weight loss

Alcohol-induced pancreatitis:

• Males 30-50 years old
• Chronic heavy alcohol use (60-70% of chronic cases) 3
• Heavy smoking increases risk

Other risk factors:

• Hypertriglyceridemia (>1000 mg/dL)
• Hypercalcemia
• Recent ERCP procedure
• Trauma to abdomen
• Certain medications (steroids, thiazides, azathioprine)
• Family history of pancreatitis

Why These Demographics Align

• Gallstones: Block the pancreatic duct where it joins the bile duct, causing enzyme backup and activation
• Alcohol: Directly toxic to pancreatic cells, causes protein plugs in ducts, increases enzyme secretion
• Hypertriglyceridemia: Fat particles damage pancreatic cells and trigger inflammation
• Trauma: Direct injury causes enzyme release

---

Signs and Symptoms Paramedics Encounter

Classic Presentation (TRANSPORT)

Severe, constant epigastric pain radiating to the back is the cardinal symptom 1, 4:

• Pain described as boring, knife-like, or band-like around upper abdomen
• Patient often leans forward or assumes fetal position for relief
• Pain worsens when lying flat
• Nausea and vomiting (often persistent and severe)
• Abdominal distension and tenderness
• Fever (low-grade initially, high fever suggests infection)
• Tachycardia and hypotension (suggests hypovolemia or shock)
• Decreased or absent bowel sounds

Severe Disease Indicators (ALWAYS TRANSPORT)

• Altered mental status or confusion
• Respiratory distress or hypoxia
• Signs of shock (cool, clammy skin; weak pulse; hypotension)
• Jaundice (yellow skin/eyes - suggests biliary obstruction)
• Grey Turner's sign (flank bruising) - indicates hemorrhagic pancreatitis
• Cullen's sign (periumbilical bruising) - indicates hemorrhagic pancreatitis
• Rigid, board-like abdomen (suggests peritonitis)

Atypical Presentations

Elderly patients may present with less pronounced abdominal pain or atypical symptoms, potentially delaying recognition 5.

---

EMS Assessment Findings

Early Assessment (First 24-48 hours)

Vital signs:

• Tachycardia (HR >100) from pain and hypovolemia
• Tachypnea (RR >20) from pain, splinting, or early ARDS
• Fever (usually low-grade 100-101°F initially)
• Hypotension (SBP <90) indicates severe disease
• Oxygen saturation may be normal or slightly decreased

Physical exam:

• Severe epigastric tenderness with guarding
• Abdominal distension
• Hypoactive bowel sounds
• Patient appears ill, diaphoretic, anxious
• Skin warm and dry initially

History red flags:

• Recent heavy alcohol binge (24-48 hours prior)
• Known gallstones or recent fatty meal
• Previous episodes of similar pain
• Recent abdominal trauma or procedure

Late Assessment (48+ hours or Severe Disease)

Vital signs indicating deterioration:

• Persistent tachycardia despite treatment
• Hypotension requiring pressors
• Hypoxia (SpO2 <90%) requiring supplemental oxygen
• High fever (>102°F) suggests infected necrosis 1

Physical exam:

• Worsening abdominal distension (suggests ileus or ascites)
• Decreased breath sounds bilaterally (pleural effusions)
• Skin cool, clammy, mottled (shock)
• Decreased urine output (renal failure)
• Altered mental status (sepsis, organ failure)
• Grey Turner's or Cullen's signs (hemorrhagic pancreatitis)

Organ failure indicators (mortality risk 15-35%) 1:

• Respiratory: Need for supplemental oxygen, respiratory distress
• Cardiovascular: Hypotension despite fluids
• Renal: Decreased urine output, confusion
• Neurological: Altered mental status, confusion

---

EMS Management and Treatment

Initial Scene Assessment and Patient Contact

1. Scene safety: Standard precautions, assess for trauma mechanism
2. Primary survey: ABCs, identify life threats
3. Position patient: Allow position of comfort (usually sitting forward or fetal position)
4. High-flow oxygen: If SpO2 <94% or respiratory distress

Focused Assessment

SAMPLE history priorities:

• Symptoms: Onset, character, radiation of pain; vomiting frequency
• Allergies: Document all
• Medications: Specifically ask about pancreatic enzymes, insulin, pain medications
• Past medical history: Previous pancreatitis, gallstones, alcohol use, diabetes
• Last oral intake: Recent alcohol, fatty meals
• Events: Trauma, recent procedures, medication changes

Vital signs: Complete set including temperature if available

Physical exam:

• Abdominal assessment: Tenderness location, guarding, rigidity, distension
• Skin assessment: Jaundice, bruising patterns
• Respiratory assessment: Work of breathing, lung sounds

Treatment Protocol (Start to Transfer)

Airway and Breathing:

• Maintain patent airway
• High-flow oxygen via non-rebreather if SpO2 <94%
• Consider CPAP if respiratory distress without hypotension
• Prepare for intubation if altered mental status or severe respiratory failure

Circulation:

• Establish large-bore IV access (18-gauge or larger) × 2 1
• Aggressive fluid resuscitation is critical: Begin isotonic crystalloid (normal saline or Lactated Ringer's) bolus 1
  • Initial bolus: 500-1000 mL over 30 minutes
  • Reassess vital signs and continue fluid administration
  • Goal: Improve perfusion, normalize heart rate, maintain blood pressure
• Monitor for fluid overload: Lung sounds, work of breathing (elderly patients at higher risk) 5

Pain Management:

• Dilaudid (hydromorphone) is preferred over morphine or fentanyl 1
• Titrate to pain relief while monitoring respiratory status
• Do NOT withhold pain medication - pain control is a clinical priority 1
• Consider antiemetics (ondansetron 4-8 mg IV) for nausea/vomiting

Monitoring:

• Continuous cardiac monitoring
• Pulse oximetry
• Blood pressure every 5-10 minutes during transport
• Capnography if available
• Document serial assessments

Transport Decision:

• ALL suspected pancreatitis patients require hospital evaluation 4
• Severe disease indicators warrant immediate transport to highest level facility:
  • Persistent hypotension despite fluids
  • Respiratory distress or hypoxia
  • Altered mental status
  • Signs of hemorrhagic pancreatitis
  • Suspected infected necrosis (high fever, septic appearance)

Communication:

• Early hospital notification for severe cases
• Report: Age, chief complaint, vital signs, fluid administered, pain management, pertinent history
• Request orders for additional pain medication or fluid boluses if needed

Special Considerations

• Elderly patients: More cautious fluid administration due to cardiac comorbidities, but monitor for renal insufficiency 5
• Pregnant patients: Left lateral tilt positioning, careful fluid management
• Diabetic patients: Monitor blood glucose if able

---

Chronic Pancreatitis Medications

Pancreatic Enzyme Replacement Therapy (PERT)

Most common medication: Pancrelipase (Creon, Zenpep, Pancreaze)

Purpose: Replaces digestive enzymes (lipase, amylase, protease) that the damaged pancreas can no longer produce adequately 2, 3

Why patients need it: When >90% of pancreatic tissue is destroyed, fat malabsorption occurs, causing:

• Steatorrhea (fatty, pale, bulky stools)
• Weight loss and malnutrition
• Fat-soluble vitamin deficiencies (A, D, E, K)

Dosing: Taken with every meal and snack

Insulin or Oral Hypoglycemics

Purpose: Manage diabetes mellitus resulting from loss of insulin-producing beta cells 3

Why patients need it: Chronic pancreatitis destroys endocrine tissue, causing "pancreatogenic diabetes" (Type 3c diabetes)

Pain Medications

Common medications: Opioids (tramadol, oxycodone, hydromorphone), gabapentin, pregabalin

Purpose: Manage chronic abdominal pain from nerve damage and inflammation

Vitamin Supplements

Common supplements: Fat-soluble vitamins (A, D, E, K), B12, calcium, magnesium

Purpose: Replace vitamins lost due to malabsorption from enzyme deficiency 2

Proton Pump Inhibitors (PPIs)

Common medications: Omeprazole, pantoprazole

Purpose: Reduce stomach acid to optimize pancreatic enzyme function and reduce pain

---

Complications of Delayed Treatment

Early Complications (First Week)

Hypovolemic shock 1:

• Mechanism: Massive fluid shifts from intravascular space into inflamed pancreas and peritoneal cavity ("third-spacing")
• Result: Hypotension, organ hypoperfusion, acute kidney injury
• Mortality impact: Significantly increases risk of organ failure

Acute respiratory distress syndrome (ARDS):

• Mechanism: Inflammatory mediators damage lung capillaries, causing pulmonary edema
• Result: Severe hypoxia requiring mechanical ventilation
• Timing: Typically develops within 48-72 hours

Acute kidney injury:

• Mechanism: Hypovolemia, inflammatory mediators, direct toxicity
• Result: Decreased urine output, electrolyte imbalances, need for dialysis

Intermediate Complications (1-4 Weeks)

Pancreatic necrosis 1:

• Mechanism: Severe inflammation causes tissue death
• Result: Creates dead tissue that can become infected
• Mortality: 19.8% with sterile necrosis and organ failure 1

Infected pancreatic necrosis 1:

• Mechanism: Bacteria colonize necrotic tissue (occurs in 20-40% of severe cases)
• Result: Sepsis, abscess formation, worsening organ failure
• Mortality: 35.2% when combined with organ failure 1
• Timing: Typically occurs after first week

Acute necrotic collections (ANC):

• Mechanism: Fluid and necrotic debris accumulate around pancreas
• Result: Can compress adjacent organs, become infected
• Timing: First 4 weeks 1

Late Complications (>4 Weeks)

Walled-off necrosis (WON):

• Mechanism: Necrotic collections become encapsulated by fibrous wall
• Result: Persistent pain, infection risk, may require drainage
• Timing: After 4 weeks 1

Pancreatic pseudocyst:

• Mechanism: Fluid collections become encapsulated
• Result: Can rupture, bleed, or become infected

Splanchnic vein thrombosis:

• Mechanism: Inflammation extends to nearby blood vessels
• Result: Portal vein thrombosis, splenic vein thrombosis, gastric varices

Abdominal compartment syndrome:

• Mechanism: Massive fluid resuscitation and inflammation increase intra-abdominal pressure
• Result: Compromises organ perfusion, respiratory function
• Requires urgent decompression

Chronic Complications

Chronic pancreatitis 3:

• Mechanism: Repeated acute episodes cause permanent scarring
• Result: Chronic pain, malabsorption, diabetes, increased cancer risk

Pancreatic insufficiency:

• Exocrine: Malabsorption, weight loss, vitamin deficiencies
• Endocrine: Diabetes mellitus requiring insulin

Increased pancreatic cancer risk:

• Mechanism: Chronic inflammation and cellular changes
• Result: Higher lifetime risk of pancreatic adenocarcinoma

Overall Mortality Impact

• Mild pancreatitis: <1% mortality
• Severe pancreatitis with organ failure: 15% mortality 1
• Infected necrosis with organ failure: 35.2% mortality 1
• Key determinant: Persistent organ failure >48 hours defines severe disease 1

Critical time window: The first 24-48 hours are crucial for aggressive fluid resuscitation to prevent organ failure and reduce mortality 1. Delayed recognition and inadequate initial fluid therapy significantly worsen outcomes.